Vitex agnus castus Extract Ze 440: Diterpene and Triterpene's Interactions with Dopamine D2 Receptor

Int J Mol Sci. 2024 Oct 25;25(21):11456. doi: 10.3390/ijms252111456.

Abstract

Pre-clinical studies suggest that extracts prepared from the fruits of Vitex agnus castus (VAC) interact with dopamine D2 receptors, leading to reduced prolactin secretion. In previous experiments, dopaminergic activity was mostly evaluated using radioligand binding assays or via the inhibition of prolactin release from rat pituitary cells. Diterpenes featuring a clerodadienol scaffold were identified as major active compounds, but no conclusive data regarding their potency and intrinsic activity are available. Utilising advances in chromatography, we re-examined this topic using HPLC-based tracking of bioactivity via microfractionation of the VAC extract Ze 440. Using a cAMP-based assay, we measured dopaminergic activity in CHO-K1 cells that overexpress the human D2 receptor. Six diterpenes were isolated from two active HPLC microfractions. Viteagnusin I emerged as the most potent diterpene (EC50: 6.6 µM), followed by rotundifuran (EC50: 12.8 µM), whereas vitexilactone was inactive (EC50: >50 µM). Interestingly, triterpenes were also identified as active, with 3-epi-maslinic acid being the most active compound (EC50: 5.1 µM). To better understand these interactions at the molecular level, selected diterpenes and triterpenes were analysed through molecular docking against D2 receptor structures. Our data show that the dopaminergic activity of VAC diterpenes seems to depend on the configuration and on ring substitution in the side chain. This study also highlights for the first time the dopaminergic contribution of triterpenes such as 3-epi-maslinic acid.

Keywords: D2 receptor; Vitex agnus castus; diterpene; microfractionation; molecular docking; triterpene.

MeSH terms

  • Animals
  • CHO Cells
  • Cricetulus*
  • Diterpenes* / chemistry
  • Diterpenes* / pharmacology
  • Humans
  • Molecular Docking Simulation*
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacology
  • Receptors, Dopamine D2* / metabolism
  • Triterpenes* / chemistry
  • Triterpenes* / pharmacology
  • Vitex* / chemistry

Substances

  • Receptors, Dopamine D2
  • Plant Extracts
  • Diterpenes
  • Triterpenes

Grants and funding

This study was funded by Max Zeller Soehne AG, CH-8590 Romanshorn, Switzerland.